Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees:
|Mr. Jay Kim||Chairman & CEO||N/A||N/A||N/A|
|Young-Ha Kim||Sr. Managing Director, Director of Marketing Division and Director||N/A||N/A||1954|
|Ho-Young Baek||Director of Operation Support Division and Director||N/A||N/A||1962|
|Daniel Chang||Chief Exec. Officer of Pharma Biz||N/A||N/A||N/A|
Boryung Corporation produces and sells pharmaceutical products in South Korea. The company offers cardiovascular products, anticancer products, gastrointestinal products, and API's. It also exports its products to approximately 50 countries on 6 continents, including Japan, China, the Southeast Asia, the Middle East, Europe, South America, and Africa. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is based in Seoul, South Korea.
Boryung Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.